Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Arq. bras. oftalmol ; 85(6): 629-631, Nov.-Dec. 2022.
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1403465

RESUMO

ABSTRACT Laser photocoagulation is a safe method for the treatment of retinal disorders. We present a case of a 21-year-old woman with high myopia, retinal detachment in the right eye, and bilateral lattice degeneration. She underwent surgical repair in the right eye followed by bilateral retinal laser therapy. During laser photocoagulation of the left eye, she experienced a generalized tonic-clonic seizure for the first time in her life. She had a positive family history of epilepsy. Neurological examination and brain magnetic resonance imaging findings were normal, but an electroencephalogram revealed epileptogenic discharges, more frequent during photostimulation. She avoided flickering lights during the 2-year follow-up, without seizure recurrence. Approximately 5% of patients with epilepsy have photosensitive epilepsy, of whom a considerable proportion will experience seizures only during exposition to flashing lights. Laser photocoagulation was already successfully employed in an animal model of photosensitive epilepsy. Personal or family history of photosensitivity warrants a neurological consultation before retinal treatment with laser therapy.


RESUMO Fotocoagulação a laser é método seguro para tratamento de retinopatias. Apresentamos o caso de uma mulher de 21 anos com alta miopia e degeneração lattice bilateral que sofreu descolamento de retina no olho direito e foi submetida a tratamento cirúrgico e ulterior laserterapia. Durante a fotocoagulação no olho esquerdo, ela teve uma convulsão tônico-clônica generalizada, a primeira em sua vida. Havia história familiar de epilepsia. O exame neurológico e a ressonância magnética de en céfalo foram normais, mas o electroencefalograma revelou descargas epileptogênicas, mais frequentes durante a fotoesti mulação. Ela evitou luzes piscantes durante os 2 anos subsequentes, sem recorrência de convulsões. Cerca de 5% dos pacientes com epilepsia têm fotossensibilidade. Proporção considerável deles terá convulsões somente durante exposição à luz piscante. Fotocoagulação a laser já foi empregada como modelo animal de sucesso para epilepsia fotossensível. Presença de fotossensibilidade na história pessoal ou familiar deve merecer avaliação neurológica antes do tratamento retiniano.

2.
Arq Bras Oftalmol ; 85(6): 629-631, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34852058

RESUMO

Laser photocoagulation is a safe method for the treatment of retinal disorders. We present a case of a 21-year-old woman with high myopia, retinal detachment in the right eye, and bilateral lattice degeneration. She underwent surgical repair in the right eye followed by bilateral retinal laser therapy. During laser photocoagulation of the left eye, she experienced a generalized tonic-clonic seizure for the first time in her life. She had a positive family history of epilepsy. Neurological examination and brain magnetic resonance imaging findings were normal, but an electroencephalogram revealed epileptogenic discharges, more frequent during photostimulation. She avoided flickering lights during the 2-year follow-up, without seizure recurrence. Approximately 5% of patients with epilepsy have photosensitive epilepsy, of whom a considerable proportion will experience seizures only during exposition to flashing lights. Laser photocoagulation was already successfully employed in an animal model of photosensitive epilepsy. Personal or family history of photosensitivity warrants a neurological consultation before retinal treatment with laser therapy.


Assuntos
Epilepsia Reflexa , Terapia a Laser , Descolamento Retiniano , Feminino , Humanos , Epilepsia Reflexa/cirurgia , Convulsões/etiologia , Convulsões/diagnóstico , Convulsões/cirurgia , Descolamento Retiniano/cirurgia , Lasers
3.
Clin. biomed. res ; 41(1): 27-32, 2021. ilus, tab
Artigo em Português | LILACS | ID: biblio-1280803

RESUMO

Introdução: A inteligência artificial (IA) está revolucionando a área da saúde. Na oftalmologia, esta tecnologia pode possibilitar diagnósticos mais rápidos e precisos, impedindo a progressão das alterações na visão. Médicos e algoritimosalgoritmos podem ser mais eficientes quando trabalham juntos. Desenvolver um software de IA com alta especificidade e sensibilidade para apoio no diagnóstico de algumas patologias oftalmológicas. Métodos: O software de deep learning foi construído através de redes neurais valendo de duas bases computacionais MobileNet e Inception. Para o treinamento do banco de dados foram utilizadas 2.520 imagens de glaucoma, retinopatia diabética, toxoplasmose ocular, papiledema, descolamento de retina e retina normal. Para a validação foi utilizado 428 imagens patológicas e normais para os cálculos de sensibilidade e de especificidade. Todas as imagens foram cedidas da Sociedade Americana de Especialistas da Retina. Resultados: Os resultados de sensibilidade e especificidade foram no MobileNet de 91% (IC 95%, 89-92%) e 98,5% (IC 95%, 98-99%); no Inception, de 91,4% (IC 95%, 89-93,5%) de 98,4% (IC 95%, 98-98,8%), respectivamente. Não houve diferença significativa entre os dois métodos utilizados. Conclusão: O software apresentou resultados promissores na distinção das condições oftalmológicas pesquisadas. (AU)


Introduction: Artificial intelligence (AI) is revolutionizing health care. In ophthalmology, this technology can enable faster and more accurate diagnoses, preventing the progression of vision Physicians and algorithms are most effective when working together. To develop an AI software with high specificity and sensitivity to support the diagnosis of some ophthalmic diseases. Methods: A deep learning software was built through neural networks using two computational bases, MobileNet and Inception. For training the database, 2520 images of glaucoma, diabetic retinopathy, ocular toxoplasmosis, papilledema, retinal detachment, and normal retina were used. For validation, 428 pathological and normal images were used for calculations of sensitivity and specificity. All images were obtained from the American Society of Retina Specialists. Results: The results of sensitivity and specificity were 91% (95% confidence interval [CI], 89-92%) and 98.5% (95% CI, 98-99%) on MobileNet, and 91.4% (95% CI, 89-93.5%) and 98.4% (95% CI, 98-98.8%) on Inception, respectively. There was no significant difference between the two methods. Conclusion: The software showed promising results in distinguishing the main ophthalmic conditions surveyed. (AU)


Assuntos
Descolamento Retiniano/diagnóstico , Papiledema/diagnóstico , Toxoplasmose Ocular/diagnóstico , Glaucoma , Retinopatia Diabética/diagnóstico , Software , Inteligência Artificial , Sensibilidade e Especificidade , Aprendizado Profundo
4.
Rev. bras. oftalmol ; 67(6): 297-302, nov.-dez. 2008. ilus, tab
Artigo em Português | LILACS | ID: lil-505182

RESUMO

OBJETIVOS: Dermopatia diabética é o marcador cutâneo mais comum de diabetes mellitus. Embora, a dermopatia e a retinopatia diabéticas sejam consideradas manifestações de microangiopatia diabética, poucos estudos foram publicados a respeito de uma possível associação. Este estudo pretendeu investigar a associação de retinopatia e dermopatia diabéticas e determinar a prevalência e os fatores de risco associados com retinopatia diabética em pacientes diabéticos do tipo 2 do Ambulatório de Diabetes da Faculdade de Medicina da Universidade de Passo Fundo no Hospital de Ensino São Vicente de Paulo. MÉTODOS: Estudo transversal de 90 pacientes diabéticos tipo 2, atendidos sucessivamente em um Ambulatório de Diabetes nos quais foi realizado exame físico dermatológico e oftalmológico. RESULTADOS: A prevalência de dermopatia diabética foi de 16,6 por cento (n = 15) e a de retinopatia diabética foi de 34,4 por cento (n = 31). Destes, 67,8 por cento (n = 21) consistiam em retinopatia não-proliferativa e 32,2 por cento (n = 10) em retinopatia proliferativa. Observou-se que a duração da doença maior do que 10 anos (p = 0,001) e idade maior que 50 anos (p = 0,014) estavam associadas à retinopatia. Não se encontrou associação entre hemoglobina glicada (p = 0,5) e glicemia de jejum (p = 0,8) com retinopatia diabética. A freqüência de retinopatia diabética em pacientes com dermopatia diabética não foi maior do que nos pacientes sem dermopatia (7,7 por cento, 7 casos, p = 0,586). Não houve associação, estatisticamente significativa, entre retinopatia e dermopatia diabéticas. CONCLUSÃO: Não se encontrou associação entre dermopatia e retinopatia diabéticas entre estes indivíduos com diabetes mellitus do tipo 2. A presença de retinopatia diabética estava associada à duração da doença e à idade avançada dos pacientes.


PURPOSE: Diabetic dermopathy is the most frequent cutaneous marker of diabetes mellitus. Although diabetic dermopathy and diabetic retinopathy are both considered as manifestations of diabetic microangiopathy, there are only few reports in the literature regarding their possible association. The purpose of this study was to investigate the association between diabetic dermopathy and diabetic retinopathy and to determine the prevalence and the associated risk factors for diabetic retinopathy in type 2 diabetes patients from the Outpatient Diabetic Clinic of the Faculty of Medicine of the University of Passo Fundo and Teaching Hospital Sao Vicente de Paulo. METHODS: Cross sectional study was performed in 90 type 2 diabetes mellitus patients who attend to the outpatient diabetic clinic, consecutively. Physical, dermatological and ophthalmologic evaluations were performed in all the patients. RESULTS: The prevalence of diabetic dermopathy was 16,6 percent (n = 15) and diabetic retinopathy was 34,4 percent (n = 31); 67,8 percent of those (n = 21) consisted of non-proliferative diabetic retinopathy and 32,2 percent (n = 10) of proliferative diabetic retinopathy. The duration of the disease greater than 10 years (p = 0,001) and age over 50 years (p = 0,014) were associated to retinopathy, but no association was found with elevated levels of HbA1c (p = 0,5) and fasting plasma glucose of 126 or higher (p = 0,8). The frequency of diabetic retinopathy in patients with diabetic dermopathy was not higher than in patients without dermopathy (7,7 percent, 7 cases, p = 0,586). There was no statistically significant association between diabetic retinopathy and diabetic dermopathy. CONCLUSION: No association between diabetic dermopathy and diabetic retinopathy in this group of type 2 diabetes patients was found. The presence of diabetic retinopathy was associated to the duration of the disease and the advanced age of the patients.

5.
Arq Bras Endocrinol Metabol ; 51(6): 987-92, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17934667

RESUMO

PURPOSE: The aim of the study was to investigate the prevalence of peripheral diabetic neuropathy (PDN) and associated characteristics among type 2 diabetic mellitus (DM2) patients in Passo Fundo, a city on Southern Brazil. BASIC PROCEDURES: A cross-sectional study was conducted with 340 patients with type 2 diabetes mellitus. Tests were performed to evaluate vibration (tuning fork), light touch (10-g monofilament), temperature, and pain (pinprick) sensations, as well as ankle reflexes and heel walking. The condition was classified as peripheral diabetic neuropathy when results in at least three of these tests were negative. The electrically induced Hoffmann reflex test was performed in a group of patients to define the criterion standard used in the assessment of clinical examination sensibility in the diagnosis of neuropathy. Sensitivity was 83%, specificity, 91%, positive predictive value, 63%, and negative predictive value, 90%. The monofilament, pinprick and deep tendon reflex were the most accurate tests in the diagnosis of neuropathy. MAIN FINDINGS: Seventy-five patients (22.1%) had peripheral diabetic neuropathy, nephropathy in 29.5% and retinopathy in 28.8%. CONCLUSIONS: Logistic regression revealed that only duration of diabetes, creatinine and glycated hemoglobin concentrations were significantly associated with neuropathy.


Assuntos
Diabetes Mellitus Tipo 2/complicações , Neuropatias Diabéticas/epidemiologia , Polineuropatias/epidemiologia , Idoso , Brasil/epidemiologia , Estudos Transversais , Nefropatias Diabéticas/epidemiologia , Nefropatias Diabéticas/etiologia , Neuropatias Diabéticas/etiologia , Retinopatia Diabética/epidemiologia , Retinopatia Diabética/etiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Polineuropatias/etiologia , Prevalência , Sensibilidade e Especificidade , Limiar Sensorial/fisiologia , Tato/fisiologia
6.
Arq. bras. endocrinol. metab ; 51(6): 987-992, ago. 2007. tab
Artigo em Inglês | LILACS | ID: lil-464292

RESUMO

PURPOSE: The aim of the study was to investigate the prevalence of peripheral diabetic neuropathy (PDN) and associated characteristics among type 2 diabetic mellitus (DM2) patients in Passo Fundo, a city on Southern Brazil. BASIC PROCEDURES: A cross-sectional study was conducted with 340 patients with type 2 diabetes mellitus. Tests were performed to evaluate vibration (tuning fork), light touch (10-g monofilament), temperature, and pain (pinprick) sensations, as well as ankle reflexes and heel walking. The condition was classified as peripheral diabetic neuropathy when results in at least three of these tests were negative. The electrically induced Hoffmann reflex test was performed in a group of patients to define the criterion standard used in the assessment of clinical examination sensibility in the diagnosis of neuropathy. Sensitivity was 83 percent, specificity, 91 percent, positive predictive value, 63 percent, and negative predictive value, 90 percent. The monofilament, pinprick and deep tendon reflex were the most accurate tests in the diagnosis of neuropathy. MAIN FINDINGS: Seventy-five patients (22.1 percent) had peripheral diabetic neuropathy, nephropathy in 29.5 percent and retinopathy in 28.8 percent. CONCLUSIONS: Logistic regression revealed that only duration of diabetes, creatinine and glycated hemoglobin concentrations were significantly associated with neuropathy.


PROPOSITO: O objetivo deste estudo foi investigar a prevalência da neuropatia diabética periférica (NDP) e características associadas entre pacientes com diabetes melito tipo 2 (DM2) na cidade de Passo Fundo, sul do Brasil. PROCEDIMENTOS BASICOS: Um estudo de corte foi realizado com 340 pacientes portadores de DM2. Testes foram conduzidos a fim de avaliar sensações de vibração (diapasão), de toque leve (monofilamento 10 g), de temperatura e de dor (agulha), bem como reflexos do tornozelo e caminhar com os calcanhares. A condição foi classificada como NDP quando os resultados em pelo menos três desses testes foram negativos. O teste reflexo de Hoffman induzido eletricamente foi conduzido em um grupo de pacientes a fim de determinar o critério padrão usado na avaliação da sensibilidade do exame clínico no diagnóstico de neuropatia. A sensibilidade foi de 83 por cento, especificidade, 91 por cento, valor preditivo positivo, 63 por cento e valor preditivo negativo, 90 por cento. O teste do monofilamento, a dor e o reflexo do tendão foram os mais precisos no diagnóstico de neuropatia. PRINCIPAIS ACHADO: Setenta e cinco pacientes (22,1 por cento) foram diagnosticados com NDP, nefropatia em 29,5 por cento e retinopatia em 28,8 por cento. CONCLUSÕES: Regressão logística revelou que somente a duração do diabetes e as concentrações de creatinina e hemoglobina glicada foram significativamente associados à neuropatia.


Assuntos
Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , /complicações , Neuropatias Diabéticas/epidemiologia , Polineuropatias/epidemiologia , Brasil/epidemiologia , Estudos Transversais , Nefropatias Diabéticas/epidemiologia , Nefropatias Diabéticas/etiologia , Neuropatias Diabéticas/etiologia , Retinopatia Diabética/epidemiologia , Retinopatia Diabética/etiologia , Prevalência , Polineuropatias/etiologia , Sensibilidade e Especificidade , Limiar Sensorial/fisiologia , Tato/fisiologia
7.
Nitric Oxide ; 16(3): 348-55, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17306574

RESUMO

Endothelial nitric oxide synthase (eNOS) haplotypes are associated with hypertension (HT) in patients with or without type 2 diabetes mellitus (T2DM). We evaluated the association of eNOS genotypes/haplotypes with the plasma concentrations of nitrite/nitrate (NO(x)), which are products of nitric oxide in HT, T2DM, and T2DM+HT patients. We studied eNOS polymorphisms in the promoter region (T-786C), in exon 7 (Glu298Asp), and in intron 4 (b/a) in 98 controls, 68 patients with HT, 66 patients with T2DM, and 86 patients with T2DM+HT. NO(x) concentrations were assessed using a chemiluminescence assay. No differences were found in genotype/allele distribution among groups. Genotypes were not associated with NO(x) concentrations. The "C-Glu-b" haplotype was more common in controls than in HT/T2DM+HT groups (21% versus 9/5%, respectively, P<0.006). This haplotype was more common in HT and T2DM+HT groups among subjects with high (82+/-38 and 90+/-33 microM, respectively) than with low (35+/-7 and 34+/-7 microM, respectively) NO(x) concentrations. Conversely, the "C-Asp-b" haplotype was more common in HT/T2DM+HT groups than healthy (21/21% versus 10%, respectively, P<0.006). The haplotype associated with lower risk of developing hypertension is also associated with higher NO(x) levels among hypertensives. Conversely, the haplotype increasing the risk of developing hypertension is associated with lower NO(x) levels in hypertensives.


Assuntos
Diabetes Mellitus Tipo 2/sangue , Haplótipos , Hipertensão/sangue , Óxido Nítrico Sintase Tipo III/genética , Óxido Nítrico/sangue , Adulto , Idoso , Diabetes Mellitus Tipo 2/enzimologia , Diabetes Mellitus Tipo 2/genética , Feminino , Frequência do Gene , Genótipo , Humanos , Hipertensão/enzimologia , Hipertensão/genética , Isoenzimas/genética , Isoenzimas/metabolismo , Masculino , Pessoa de Meia-Idade , Nitratos/sangue , Óxido Nítrico Sintase Tipo III/metabolismo , Nitritos/sangue , Polimorfismo Genético , Fatores de Risco
8.
Nitric Oxide ; 15(4): 417-22, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16581274

RESUMO

Polymorphisms in the endothelial nitric oxide synthase (eNOS) gene have been associated with the development of diabetic retinopathy (DR) in patients with type 1 diabetes mellitus (T1DM), but not with T2DM. However, no previous study has analyzed combinations of genetic markers (haplotypes), which can be more informative. We studied three eNOS genetic polymorphisms: a single nucleotide polymorphism in the promoter region (T(-786)C), in exon 7 (Glu298Asp), and a variable number of tandem repeats in intron 4 (b/a) in 103 healthy controls, and in 170 patients with T2DM (without DR, N=114; with DR, N=56). We also examined the association of eNOS gene haplotypes with T2DM and with DR. No differences were found in the frequencies of genotypes and alleles of the three polymorphisms among the three groups of subjects. However, the "C-Glu-b" haplotype was more common in healthy controls (24%) than in T2DM patients (7%) (P=0.0001). Finally, no significant difference in the distribution of eNOS haplotypes frequencies was found when T2DM patients with or without DR were compared (P=0.7372). These findings suggest no association between DR and individual eNOS haplotypes in T2DM patients. The "C-Glu-b" haplotype, however, may have a protective effect against T2DM. Further studies should be conducted to address the molecular basis for such an effect.


Assuntos
Diabetes Mellitus Tipo 2/complicações , Retinopatia Diabética/genética , Óxido Nítrico Sintase Tipo III/genética , Adulto , Diabetes Mellitus Tipo 2/enzimologia , Retinopatia Diabética/enzimologia , Éxons , Feminino , Genótipo , Haplótipos , Humanos , Íntrons , Masculino , Pessoa de Meia-Idade , Polimorfismo Genético , Regiões Promotoras Genéticas
9.
Atherosclerosis ; 189(1): 241-6, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16427644

RESUMO

Type 2 diabetes mellitus (T2DM) and hypertension (HT) commonly coexist. While endothelial nitric oxide synthase (eNOS) haplotypes have been associated with HT, it is unknown whether eNOS genotypes/haplotypes are associated with altered susceptibility to HT in patients with T2DM. We studied the distribution of three eNOS genetic polymorphisms: a single nucleotide polymorphism in the promoter region (T(-786)C), in exon 7 (Glu298Asp), and a variable number of tandem repeats in intron 4(b/a). Genotypes were determined for 102 healthy controls, 119 patients with HT, 66 patients with T2DM, and 113 patients with T2DM+HT. In addition, we also compared the distribution of eNOS haplotypes in the four groups of subjects. No differences were found in genotype and allele distribution among the four groups. Conversely, the haplotypes "C Glu b" and "C Asp b" were, respectively, more and less common in healthy controls than in HT or in T2DM+HT groups (24% versus 6% and 5%, respectively; both P<0.00625; and 8% versus 18% and 18%, respectively; both P<0.00625). Moreover, DM patients presented an overall distribution of eNOS haplotypes that was not different from healthy controls (P>0.05). Additionally, the haplotypes "C Glu b" and "C Asp b" were, respectively, more and less common in T2DM group than in T2DM+HT group (19% versus 5%; and 7% versus 18%, respectively; both P<0.00625). Our findings suggest a protective effect for eNOS haplotype "C Glu b" against the development of hypertension, and that haplotype "C Asp b" increases the susceptibility to hypertension in patients without or with T2DM.


Assuntos
DNA/genética , Diabetes Mellitus Tipo 2/complicações , Predisposição Genética para Doença , Hipertensão/genética , Óxido Nítrico Sintase Tipo III/genética , Polimorfismo Genético , Alelos , Diabetes Mellitus Tipo 2/enzimologia , Feminino , Haplótipos , Humanos , Hipertensão/complicações , Hipertensão/enzimologia , Masculino , Pessoa de Meia-Idade , Óxido Nítrico Sintase Tipo III/sangue , Reação em Cadeia da Polimerase , Prognóstico , Fatores de Risco
10.
Rev. bras. oftalmol ; 58(2): 109-13, fev. 1999. tab
Artigo em Português | LILACS | ID: lil-246912

RESUMO

Objetivos: Avaliar as complicaçöes oftalmológicas secundárias à retençäo de material cristaliniano após cirurgia da catarata por técnica de facoemulsificaçäo ou facectomia extracapsular. Pacientes e métodos: Foram estudados quinze olhos de quinze pacientes que apresentaram retençäo de material cristaliniano após cirurgia de catarata. Os pacientes foram estudados em relaçäo ao tipo de cirurgia, ao intervalo entre a cirurgia e o exame e quanto a complicaçöes oftalmológicas encontradas. Resultados: O exame oftalmológico foi realizado entre três dias e quatro meses após a cirurgia da catarata. Todos os quinze olhos estudas (100 por cento) apresentaram baixa de acuidade visual acentuada (£ 20/200). Treze olhos (86,7 por cento) apresentaram reaçäo inflamatória significativa. Sete olhos (46,7 por cento) apresentaram pressäo intra-ocular maior do que 25mmHg, sete olhos (46,7 por cento) apresentaram edema ou opacificaçäo de córnea e um olho (6,7 por cento) apresentou descolamento de retina. Conclusäo: A luxaçäo do núcleo para a cavidade vítrea ou a retençäo de material cristaliniano säo mal tolerados pelo olho e podem causar complicaçöes oculares graves. O controle clínico é geralmente inefetivo, havendo, portanto, indicaçäo de remoçäo cirúrgica do material cristaliniano como forma de tratar, ou mesmo de previnir essas complicaçöes...


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Extração de Catarata , Facoemulsificação/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...